Table 4.
Univariate and multivariate analyses to assess the prognostic factors in propensity score matched 166 gastric cancer patients with normal serum CEA levels
| Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | p value | ||
| Gender | female / male | 0.652 | 0.230–1.631 | 0.370 | |||
| pStage | I, II / III | 7.303 | 2.827–22.468 | < 0.001 | 7.803 | 3.015–24.041 | < 0.001 |
| Tumor size | < 5 / ≥ 5 | 1.735 | 0.710–4.618 | 0.230 | |||
| PNI | ≥ 44.3 / < 44.3 | 2.742 | 1.100–7.745 | 0.030 | 3.078 | 1.232–8.707 | 0.016 |
| Diff. | well & mod / poor | 1.588 | 0.657–4.054 | 0.306 | |||
| BMI | ≥ 18.5 / < 18.5 | 1.050 | 0.245–3.125 | 0.939 | |||
| Adjuvant | No / Yes | 2.419 | 1.000–6.179 | 0.050 | |||
HR Hazard ratio, CI Confidence interval, PNI Prognostic nutritional index, CEA Carcinoembryonic antigen, pStage Pathological Stage, Diff Differentiation, BMI Body mass index, Adjuvant adjuvant chemotherapy